Duopharma Biotech Bhd
KLSE:DPHARMA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.13
1.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Duopharma Biotech Bhd
Total Current Liabilities
Duopharma Biotech Bhd
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Total Current Liabilities
myr160.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
16%
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Total Current Liabilities
myr36.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
22%
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Total Current Liabilities
myr190.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Total Current Liabilities
myr27.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Total Current Liabilities
myr89.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Total Current Liabilities
myr51.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
See Also
What is Duopharma Biotech Bhd's Total Current Liabilities?
Total Current Liabilities
160.3m
MYR
Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Total Current Liabilities amounts to 160.3m MYR.
What is Duopharma Biotech Bhd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
16%
Over the last year, the Total Current Liabilities growth was -45%. The average annual Total Current Liabilities growth rates for Duopharma Biotech Bhd have been -7% over the past three years , -10% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
